WebinarsNew
Explore Business Standard
HDFC Bank
The Bombay High Court on Tuesday dismissed an interim plea filed by the medical trust that runs Lilavati Hospital here, seeking to restrain the HDFC Bank, its Managing Director and CEO Sashidhar Jagdishan and others from making any defamatory remarks against the trust and its members. The Lilavati Kirtilal Mehta Medical Trust had filed the interim application in a defamation suit seeking Rs 1,000 crore damages from the bank, alleging that it and its senior executives had allegedly released statements to the media and also on its social media platforms that were defamatory and harmed the reputation of the trust. A bench of Justice Somasekhar Sundaresan, while dismissing the application, however, noted that the statements were not defamatory and were in fact factually accurate. The court also imposed a cost of Rs 5 lakh on the trust, which would have to be paid to the HDFC Bank, while noting that the application was just another plea in the long chain of proceedings initiated by the .
Private sector lender HDFC Bank has increased the Marginal Cost of funds-based Lending Rate (MCLR) by up to 10 basis points across tenors effective June 8, 2026. The maximum hike of 10 basis points was for loans having a maturity of two years to 8.55 per cent from the earlier 8.45 per cent. The benchmark one-year MCLR has been revised up by 5 basis points to 8.40 per cent, as per the data available on the HDFC Bank website. The one-year rate is used to fix most consumer loans, such as auto, personal and home loans. The overnight, three-month, six-month and three-year tenor MCLRs have been raised by 5 basis points to 8.10 per cent, 8.20 per cent, 8.35 per cent and 8.65 per cent, respectively. The MCLR hike decision comes days after the Reserve Bank on Friday expectedly kept interest rates unchanged for the second time in a row as it weighed the impact of rising energy prices and supply disruptions caused by the West Asia crisis.